In breast cancer, GALNT6 is related with poor prognosis of patients, and promotes the proliferation, epithelial-mesenchymal transition, migration, and invasion of cancer cells via O-glycosylation and stabilization of fibronectin [29] or mucin 1 [36]. Here, MUC1 is linked to breast cancer.